Adjuvant therapy for breast cancer: a brief overview of the NSABP experience and some thoughts on neoadjuvant chemotherapy

Recent Results Cancer Res. 1986:103:54-68. doi: 10.1007/978-3-642-82671-9_6.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Age Factors
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / surgery
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Doxorubicin / administration & dosage
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Lymphatic Metastasis
  • Melphalan / administration & dosage
  • Melphalan / therapeutic use
  • Methotrexate / administration & dosage
  • Middle Aged
  • Receptors, Estrogen / metabolism
  • Tamoxifen / administration & dosage

Substances

  • Receptors, Estrogen
  • Tamoxifen
  • Doxorubicin
  • Melphalan
  • Fluorouracil
  • Methotrexate